Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours. [PDF]
Hallet J, Søreide K.
europepmc +1 more source
Clinical characteristics and treatment patterns of patients with gastroenteropancreatic neuroendocrine neoplasia in Germany receiving peptide receptor radionuclide therapy: A real-world data registry-based study. [PDF]
von Hessert-Vaudoncourt C+10 more
europepmc +1 more source
Treatment of an Aggressive Gonadotroph Pituitary Neuroendocrine Tumor With 177Lutetium DOTATATE Radionuclide Therapy. [PDF]
Gandhi C, Koumna S, Chik C.
europepmc +1 more source
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. [PDF]
Waked A+7 more
europepmc +1 more source
Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors. [PDF]
Gujarathi R+4 more
europepmc +1 more source
Image-Guided Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionuclide Therapy for Glioblastoma. [PDF]
Shah S, Lucke-Wold B.
europepmc +1 more source
Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model. [PDF]
Saidi A+3 more
europepmc +1 more source